Rachel Weichao Zhai, Ph.D.

Senior Manager, LIVE Ventures (New Ventures Program) @ Duke-NUS Medical School

About

Capabilities: Investment: Deal sourcing and in-depth technology and technology landscape analysis revolving healthcare and deep-tech ventures. Networking: Creating and strengthening a network of local and overseas entrepreneurs and investment professionals in healthcare and deep-tech domains. Research: cell-derived products (exosomes), label-free monitoring for cell manufacturing, automated single-cell imaging, microfluidics devices Industry Development: Performing technology scouting and pushing lab-based technology for commercialization and technology partnerships Entrepreneurship: Cambridge Judge Business School, Enterprises/EnterpriseWISE program

Country

City

Singapore

Industry

Venture Capital & Private Equity

Skill

Private Equity, Corporate Governance, Regulatory Compliance, Start-up Ventures, Enterprise Risk Management, Financial Modeling, Portfolio Management, Fund Management, Venture Creation, Venture Capital, Investment Valuation, DCF Valuation, Financial Analysis, Project Management, Professional Networking, Stakeholder Management, Stakeholder Engagement, Strategic Planning, Publications, Stem Cell Therapy

Experience

Senior Manager, LIVE Ventures (New Ventures Program)

Duke-NUS Medical School

2024-4 - Present · 2 yrs 6 mos

Senior Associate, Investment

Vertex Network

2021-12 - 2024-4 · 2 yrs 5 mos

Skilled in deal sourcing and in-depth analysis revolving healthcare and deep-tech ventures. Active in creating a network of entrepreneurs and investment professionals in the related domains.

Events Lead

Biotech Connection Singapore

2020-7 - 2022-6 · 2 yrs

Lead the BCS-EVX partnership event on Biotech Financing Models, Biotech in Singapore (Biotech entrepreneurs) and BCS startup series on startup strategy in accessing the Chinese Market.

Assistant Head, Precision Medicine and Digital Health, Biomedical Research Council

A*STAR - Agency for Science, Technology and Research

2021-4 - 2021-12 · 9 mos

Public sector account and stakeholder management, public sector and programmatic fund projects management, BiomedDAR strategy and value proposition to the local ecosystem.

Project Lead

A*STAR - Agency for Science, Technology and Research

2020-8 - 2021-4 · 9 mos

Label-free isolation of iPSCs and MSCs derived extracellular vesicles (EVs) for cell manufacturing and therapy applications.

Research Scientist

A*STAR - Agency for Science, Technology and Research

2019-4 - 2021-4 · 2 yrs 1 mo

Singapore

Bio-manufacturing Technology (BMT): focus on label-free quantification of senescent human mesenchymal stromal cells (MSCs) for on spot cell monitoring.